Aglepristone

Jump to: navigation, search
Aglepristone
Aglepristone.png
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC29H37NO2
Molar mass431.610 g/mol
3D model (JSmol)

WikiDoc Resources for Aglepristone

Articles

Most recent articles on Aglepristone

Most cited articles on Aglepristone

Review articles on Aglepristone

Articles on Aglepristone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Aglepristone

Images of Aglepristone

Photos of Aglepristone

Podcasts & MP3s on Aglepristone

Videos on Aglepristone

Evidence Based Medicine

Cochrane Collaboration on Aglepristone

Bandolier on Aglepristone

TRIP on Aglepristone

Clinical Trials

Ongoing Trials on Aglepristone at Clinical Trials.gov

Trial results on Aglepristone

Clinical Trials on Aglepristone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Aglepristone

NICE Guidance on Aglepristone

NHS PRODIGY Guidance

FDA on Aglepristone

CDC on Aglepristone

Books

Books on Aglepristone

News

Aglepristone in the news

Be alerted to news on Aglepristone

News trends on Aglepristone

Commentary

Blogs on Aglepristone

Definitions

Definitions of Aglepristone

Patient Resources / Community

Patient resources on Aglepristone

Discussion groups on Aglepristone

Patient Handouts on Aglepristone

Directions to Hospitals Treating Aglepristone

Risk calculators and risk factors for Aglepristone

Healthcare Provider Resources

Symptoms of Aglepristone

Causes & Risk Factors for Aglepristone

Diagnostic studies for Aglepristone

Treatment of Aglepristone

Continuing Medical Education (CME)

CME Programs on Aglepristone

International

Aglepristone en Espanol

Aglepristone en Francais

Business

Aglepristone in the Marketplace

Patents on Aglepristone

Experimental / Informatics

List of terms related to Aglepristone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Aglepristone (INN) (brand name Alizine; former code names RU-46534, RU-534) is a steroidal antiprogestin (progesterone receptor full antagonist) related to mifepristone which is marketed by Virbac in several European countries for use in veterinary medicine.[1][2][3] It is specifically used as an abortifacient in pregnant.[1][3][4] Aglepristone, similarly to mifepristone, also possesses some antiglucocorticoid activity.[citation needed]

References

  1. 1.0 1.1 John D. Bonagura; David C. Twedt (1 December 2013). Kirk's Current Veterinary Therapy XV. Elsevier Health Sciences. pp. 3009–. ISBN 978-0-323-22762-9.
  2. E. James Squires (2010). Applied Animal Endocrinology. CABI. pp. 207–. ISBN 978-1-84593-755-3.
  3. 3.0 3.1 Mark G. Papich (3 November 2010). Saunders Handbook of Veterinary Drugs: Small and Large Animal. Elsevier Health Sciences. pp. 120–. ISBN 1-4377-0192-2.
  4. Patrick W. Concannon (2001). Advances in reproduction in dogs, cats and exotic carnivores: proceedings of the fourth International Symposium on Canine and Feline Reproduction, Oslo, Norway, 29 June-1 July 2000. Journal of Reproduction and Fertility. ISBN 978-0-906545-37-9.

Linked-in.jpg